ADMA accumulation, most often seen in CKD and hypertension, specifically causes decreased bioavailable NO, impaired vasodilation, increased oxidative stress, and the ability to increase TGF-β1 and collagen deposition as a fibrotic response [105]. Here, TGFB1 is linked to hypertensive disorder.